Principal Investigator
Cynthia Levy
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20240100
Clinical Trial Summary
A Phase III Randomised, Parallel-Group, Double-Blind, Placebo-Controlled, Two-Arm Study to Evaluate the Efficacy and Safety of Elafibranor 80 mg on Long-Term Clinical Outcomes in Adult Participants with Primary Biliary Cholangitis (PBC)
Phase
Phase III
Funding Agency/Sponsor
Industry
Disease
PBC (Primary Biliary Cholangitis)
Contact Information
Study Contact
Sonia Carvalho
Phone Number
+1 (305) 2434639
Email
scarvalho@miami.edu